Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Molecular biology of dysplasia and cancer in inflammatory bowel disease.

Itzkowitz SH.

Gastroenterol Clin North Am. 2006 Sep;35(3):553-71. Review.

PMID:
16952740
2.

Low frequency of colorectal dysplasia in patients with long-standing inflammatory bowel disease colitis: detection by fluorescence endoscopy.

Ochsenkühn T, Tillack C, Stepp H, Diebold J, Ott SJ, Baumgartner R, Brand S, Göke B, Sackmann M.

Endoscopy. 2006 May;38(5):477-82.

PMID:
16767582
3.

Incidence of neoplasms in patients who develop sustained leukopenia during or after treatment with 6-mercaptopurine for inflammatory bowel disease.

Disanti W, Rajapakse RO, Korelitz BI, Panagopoulos G, Bratcher J.

Clin Gastroenterol Hepatol. 2006 Aug;4(8):1025-9. Epub 2006 Jun 9.

PMID:
16765651
4.

Predictive and protective factors associated with colorectal cancer in ulcerative colitis: A case-control study.

Velayos FS, Loftus EV Jr, Jess T, Harmsen WS, Bida J, Zinsmeister AR, Tremaine WJ, Sandborn WJ.

Gastroenterology. 2006 Jun;130(7):1941-9.

PMID:
16762617
5.

Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis.

Rutter MD, Saunders BP, Wilkinson KH, Rumbles S, Schofield G, Kamm MA, Williams CB, Price AB, Talbot IC, Forbes A.

Gastroenterology. 2006 Apr;130(4):1030-8.

PMID:
16618396
6.

Chemoprevention of colorectal neoplasia in ulcerative colitis: the effect of 6-mercaptopurine.

Matula S, Croog V, Itzkowitz S, Harpaz N, Bodian C, Hossain S, Ullman T.

Clin Gastroenterol Hepatol. 2005 Oct;3(10):1015-21.

PMID:
16234048
7.

Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine.

Kandiel A, Fraser AG, Korelitz BI, Brensinger C, Lewis JD.

Gut. 2005 Aug;54(8):1121-5.

8.
9.

Statins and the risk of colorectal cancer.

Poynter JN, Gruber SB, Higgins PD, Almog R, Bonner JD, Rennert HS, Low M, Greenson JK, Rennert G.

N Engl J Med. 2005 May 26;352(21):2184-92.

10.

Risk of haematopoietic cancer in patients with inflammatory bowel disease.

Askling J, Brandt L, Lapidus A, Karlén P, Björkholm M, Löfberg R, Ekbom A.

Gut. 2005 May;54(5):617-22.

11.

Consensus conference: Colorectal cancer screening and surveillance in inflammatory bowel disease.

Itzkowitz SH, Present DH; Crohn's and Colitis Foundation of America Colon Cancer in IBD Study Group.

Inflamm Bowel Dis. 2005 Mar;11(3):314-21. Review.

PMID:
15735438
12.

Molecular underpinnings of cancer in ulcerative colitis.

Brentnall TA.

Curr Opin Gastroenterol. 2003 Jan;19(1):64-8.

PMID:
15699896
13.

Long-term follow-up after polypectomy treatment for adenoma-like dysplastic lesions in ulcerative colitis.

Odze RD, Farraye FA, Hecht JL, Hornick JL.

Clin Gastroenterol Hepatol. 2004 Jul;2(7):534-41.

PMID:
15224277
14.

Diagnosis and management of dysplasia in patients with inflammatory bowel diseases.

Itzkowitz SH, Harpaz N.

Gastroenterology. 2004 May;126(6):1634-48. Review.

PMID:
15168373
15.

Infliximab in inflammatory bowel disease: clinical outcome in a population based cohort from Stockholm County.

Ljung T, Karlén P, Schmidt D, Hellström PM, Lapidus A, Janczewska I, Sjöqvist U, Löfberg R.

Gut. 2004 Jun;53(6):849-53.

16.
17.

Small intestinal adenocarcinoma in Crohn's disease: a case-control study.

Solem CA, Harmsen WS, Zinsmeister AR, Loftus EV Jr.

Inflamm Bowel Dis. 2004 Jan;10(1):32-5.

PMID:
15058524
18.

Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis.

Rutter M, Saunders B, Wilkinson K, Rumbles S, Schofield G, Kamm M, Williams C, Price A, Talbot I, Forbes A.

Gastroenterology. 2004 Feb;126(2):451-9.

PMID:
14762782
19.

Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis.

Rutter MD, Saunders BP, Schofield G, Forbes A, Price AB, Talbot IC.

Gut. 2004 Feb;53(2):256-60.

20.

Gross versus microscopic pancolitis and the occurrence of neoplasia in ulcerative colitis.

Mathy C, Schneider K, Chen YY, Varma M, Terdiman JP, Mahadevan U.

Inflamm Bowel Dis. 2003 Nov;9(6):351-5.

PMID:
14671483

Supplemental Content

Support Center